Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-16

Clinical Trial Update: Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

This Phase 2 trial update reports on combining lapatinib with temozolomide and regional radiation therapy for patients with newly diagnosed glioblastoma, and no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lapatinib (Lapatinib)
  • Temodar (Temozolomide)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Newly Diagnosed Glioblastoma Multiforme | Phase 2 | Status: COMPLETED